AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments By Reuters
By Maggie Fick and Yadarisa Shabong (Reuters) -Drugmaker AstraZeneca (NASDAQ:) lifted its annual gross sales and revenue forecast for the...
investments
funding methods: Dalal Avenue Week Forward: Guard earnings at greater ranges, rotate investments in fatigued market
The markets consolidated all through the previous week; the week was a shortened one with Monday, June 17, being a...
